Invasive fungal infection: Difference between revisions
From IDWiki
(→) |
No edit summary |
||
| Line 6: | Line 6: | ||
* ''[[Penicillium]]'' |
* ''[[Penicillium]]'' |
||
* Others... |
* Others... |
||
| + | |||
| + | == Epidemiology == |
||
| + | |||
| + | * Among patients on posaconazole for a hematologic malignancy or bone marrow transplant, there is an approximately 2% rate of breakthrough infection |
||
[[Category:Infectious syndromes]] |
[[Category:Infectious syndromes]] |
||
Revision as of 16:37, 22 September 2019
Organisms
- Aspergillus
- Mucormycosis
- Cryptococcus?
- Penicillium
- Others...
Epidemiology
- Among patients on posaconazole for a hematologic malignancy or bone marrow transplant, there is an approximately 2% rate of breakthrough infection
References
- ^ Oliver A. Cornely, Johan Maertens, Drew J. Winston, John Perfect, Andrew J. Ullmann, Thomas J. Walsh, David Helfgott, Jerzy Holowiecki, Dick Stockelberg, Yeow-Tee Goh, Mario Petrini, Cathy Hardalo, Ramachandran Suresh, David Angulo-Gonzalez. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia. New England Journal of Medicine. 2007;356(4):348-359. doi:10.1056/nejmoa061094.
